Back to overview

Dr Regina Neuefeind, LL.M.

Partner
German Patent Attorney
European Patent Attorney
Biologist

Regina Neuefeind advises and represents clients in securing, defending, enforcing and challenging intellectual property rights in Germany, Europe and around the world. Her main professional activities relate to the preparation of freedom-to-operate and validity opinions and due diligence analyses. She also represents clients in complex opposition, nullity and infringement proceedings in the fields of molecular biology, biochemistry, biotechnology and pharmaceuticals, with special focus on protein-based drugs and biosimilars as well as plant biotechnology.

Contact
T +49 (0)89 747 266 0
F +49 (0)89 776 424
E Neuefeind@maiwald.eu
Contact data VCF | Vita PDF
Career

Since 2001

Partner, shareholder and managing director at Maiwald

Since 1999

Patent attorney at Maiwald

1996-1999

Patent attorney trainee at Maiwald

Education

2004-2006

Master’s degree in „European Intellectual Property Law“ (LL.M.) from the University of Hagen with a focus on "European and International Civil Procedure Law" and "Patent Infringement and Nullity in England and France"

2001

Admitted to practice as European patent attorney

1999

Admitted to practice as German patent attorney

1996-1998

Studied law for patent attorneys at the University of Hagen

1995

Postdoc research work at the Max Planck Institute for Plant Breeding Research

1992-1994

Doctoral degree in biology from the University of Hohenheim (doctoral research at the Institute for Biotechnology of Bayer AG, Crop Science)

1991:

Diploma thesis at the Institute for Genetics of the University of Cologne

1986-1990

Studied biology, biochemistry and pharmacology at the University of Cologne and the University of Sussex
Practice Areas
Services
  • Patent prosecution and portfolio management
  • Filing strategies and drafting patent applications
  • Supplementary protection certificates proceedings  
  • Freedom-to-operate and validity analysis
  • Opposition and nullity proceedings
  • Patent litigation
  • Strategic consulting for biosimilar development
Recognitions
  • Recommended in Handelsblatt | Best Lawyers "Germany's Best Lawyers" 2020, 2021
  • For many years "frequently recommended lawyer" in the JUVE Handbook of Commercial Law Firms
Important cases
  • Representation in various opposition and appeal proceedings before the European Patent Office concerning blockbusters such as Humira®, Herceptin®, Mabthera® and Avastin®
Memberships
  • German Patent Attorney Association
  • epi
  • GRUR
  • FICPI
Languages

German, English